Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Pekka Hannonen"'
Autor:
Tuija Väänänen, Katriina Vuolteenaho, Hannu Kautiainen, Riina Nieminen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Markku J Kauppi, Kari Laiho, Oili Kaipiainen-Seppänen, Riitta Luosujärvi, Tea Uusitalo, Toini Uutela, Marjatta Leirisalo-Repo, Eeva Moilanen, NEO-RACo Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183294 (2017)
YKL-40, a chitinase-like glycoprotein associated with inflammation and tissue remodeling, is produced by joint tissues and recognized as a candidate auto-antigen in rheumatoid arthritis (RA). In the present study, we investigated YKL-40 as a potentia
Externí odkaz:
https://doaj.org/article/6049803f74e6424a87fd85ebba81496f
Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases
Publikováno v:
SAGE Open Medicine, Vol 4 (2016)
Objective: To describe a one-stop, integrated rheumatology service and assess patient satisfaction. Methods: A descriptive report and patient satisfaction survey of a rheumatology clinic model first developed in 1996 to enhance the patient “journey
Externí odkaz:
https://doaj.org/article/85f38fe0307e4e4086319dcf51e451b6
Publikováno v:
Clinical and experimental rheumatology.
To study 10-year outcomes in patients with early seropositive rheumatoid arthritis (RA) whether the outcomes improve over time.Data of 1754 patients with early RA, diagnosed in 1997-2011 were explored; 66% (n=1151) were seropositive and included in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2456a0e936e29d8c4fff3959ba82cd89
https://pubmed.ncbi.nlm.nih.gov/35765993
https://pubmed.ncbi.nlm.nih.gov/35765993
Autor:
Pekka Hannonen, Tia Sandström, Timo Malmi, Kari Puolakka, Vappu Rantalaiho, T Uutela, Leena Paimela, Anna Karjalainen, Heikki Julkunen, Timo Möttönen, Leena Laasonen, Marjatta Leirisalo-Repo, Hannu Kautiainen, Oili Kaipiainen-Seppänen, Tea Uusitalo, Timo Yli-Kerttula, Markku J Kauppi
Publikováno v:
The Journal of Rheumatology. 47:1160-1164
Objective.To evaluate the development of radiological changes of the cervical spine in patients with rheumatoid arthritis (RA) in the NEO-RACo trial treated with an intensive, remission-targeted combination of conventional synthetic disease-modifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27070f34d2420c124cfcbfbb5c92ac2c
https://doi.org/10.3899/jrheum.190139
https://doi.org/10.3899/jrheum.190139
Publikováno v:
Rheumatology (Oxford, England)
Objectives The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. Methods Using nationwide Finnish registers from social insuranc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a0b0f851358fd4f9fbe936014bb141
https://pubmed.ncbi.nlm.nih.gov/33569582
https://pubmed.ncbi.nlm.nih.gov/33569582
Publikováno v:
Rheumatology. 60:2493-2494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37545bdf3b6d165ab4cfa4d9f3fe5fae
https://doi.org/10.1093/rheumatology/keaa861
https://doi.org/10.1093/rheumatology/keaa861
Autor:
Markku Kauppi, Markku Mali, J Asikainen, L Kuusalo, M Puurtinen-Vilkki, P. Isomäki, Kirsi Taimen, J Paltta, Laura Pirilä, Kari Laiho, T Rannio, T. Yli-Kerttula, Hannu Kautiainen, Tuulikki Sokka, T. Uotila, Pekka Hannonen, S. Nyrhinen, Kalle Aaltonen, S. Kortelainen, P Ekman, Heidi Mäkinen
Publikováno v:
Scandinavian Journal of Rheumatology. 46:425-431
To assess what proportion of patients with disease-modifying anti-rheumatic drug (DMARD)-naïve early rheumatoid arthritis (ERA) reach 28-joint Disease Activity Score (DAS28) remission over 1 year, and remission variability across clinics in Finland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9deb535232344ae66086d53ee36f4f3
https://doi.org/10.1080/03009742.2016.1266029
https://doi.org/10.1080/03009742.2016.1266029
Autor:
Kirsi, Paalanen, Katja, Rannio, Tuomas, Rannio, Juha, Asikainen, Pekka, Hannonen, Tuulikki, Sokka
Publikováno v:
Clinical and experimental rheumatology. 38(1)
We aimed to characterise the clinical and radiographical phenotype of calcium pyrophosphate dihydrate deposition (CPPD) disease in patients initially diagnosed with seronegative RA, and to increase the awareness that CPPD disease can be falsely diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2646a6959a96eab2d33f6bbeb05c89b
https://pubmed.ncbi.nlm.nih.gov/31140401
https://pubmed.ncbi.nlm.nih.gov/31140401
AB0256 Differential diagnosis of seronegative ra: calcium pyrophosphate dihydrate deposition disease
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background Calcium pyrophosphate deposition (CPPD) disease is caused by calcium pyrophosphate (CPP) crystals and seen mainly in elderly. Clinical presentation can be heterogeneous. The arthropathy of CPPD may mimic RA, particularly if involving commo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d88c69962b1e92e6cd6c06893c513baa
https://doi.org/10.1136/annrheumdis-2018-eular.3244
https://doi.org/10.1136/annrheumdis-2018-eular.3244
Autor:
Elena, Nikiphorou, Pekka, Hannonen, Juha, Asikainen, Jelena, Borodina, Arto, Kokko, Kirsi, Paalanen, Tuomas, Rannio, Tuulikki, Sokka
Publikováno v:
Clinical and experimental rheumatology. 37(1)
Reports to-date indicate similarity between infliximab biosimilar (IB) and infliximab bio-original (IO) in clinical efficacy and safety. This study examines the survival of IB and IO using routinely collected data over a 2-year period.Routinely colle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a8e8f22c342a796201c6cee7bb2c538
https://pubmed.ncbi.nlm.nih.gov/29998827
https://pubmed.ncbi.nlm.nih.gov/29998827